Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Methanothermococcus

ABSTRACT: Methanothermococcus single cell amplified whole genome sequencing

PROVIDER: PRJNA477509 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR7415040_1.fastq.gz	Fastqsanger.gz
	SRR7415040_2.fastq.gz	Fastqsanger.gz
	SRR7415041_1.fastq.gz	Fastqsanger.gz
	SRR7415041_2.fastq.gz	Fastqsanger.gz
	SRR7415042_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 10

Similar Datasets

subsurface metagenome

Project description:Single cell amplified Methanothermococcus genomic sequencing

| PRJNA476142 | ENA

Methanothermococcus okinawensis IH1

Project description:Methanothermococcus okinawensis IH1 genome sequencing

| PRJNA43653 | ENA

Methanothermococcus okinawensis

Project description:Methanothermococcus okinawensis overview

| PRJNA43677 | ENA

Methanothermococcus thermolithotrophicus

Project description:Methanothermococcus thermolithotrophicus overview

| PRJNA35681 | ENA

Methanothermococcus thermolithotrophicus DSM 2095

Project description:Methanothermococcus thermolithotrophicus DSM 2095

| PRJNA182394 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

SNPchip analysis of single cell products

2007-12-20 | GSE8567 | GEO

Genotyping of human cell lines with amplification of single cell vs. non amplied products to examime the effect of allele bias during amplification

Project description:Single-cell human genome analysis using whole-genome amplified product is hampered by allele bias during amplification. Using an oligonucleotide SNP array, we examined the nature of the allele bias and its effect on the chromosomal copy number analysis. Experiment Overall Design: TB106, lymphoblastoid cell line; CMK11-5 and CMK86, cell line; WGA, whole-genome amplified from bulk DNA; SC, whole-genome amplified product from single cell. Genotype and copy number status were compared between non-amplified products and their single cell products.

2008-06-16 | E-GEOD-8567 | biostudies-arrayexpress

cDNA aCGH study of whole genome amlification effect on analysis of FFPE microdissected human breast cancer

Project description:6 samples of FFPE breast cancer tissue, whole genome amplification methods tested for fidelity: 3 samples amplified by two techniques (SCOMP and DOP) and compaed to non amplified control, 3 samples amplified additionally by the better performing technique (SCOMP) Keywords: Pre-clinical method validation, whole genome amplification for use with aCGH

2008-02-10 | GSE10456 | GEO

Project description:Marine single-cell amplified genomes

| PRJNA743799 | ENA